Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Treatment with defactinib showed an increase in FAK, paxillin, and dual FAK-paxillin containing focal adhesions from 0.1 to 3.1 M, but at higher doses, defactinib was able to reduce the amount of FAK and paxillin containing FAs with an IC 50 value of 11.11 M and 18.65 M respectively (Fig
E.LermanJ
For users who prefer a non injectable, evidence backed product, Motus can be a practical part of a broader, diet and exercise focused plan.
Free Download: Peptide Protocol Planner (12-Week) Plan your CJC-1295/Ipamorelin combination protocol with our 12-week planner
Hect JL, Daugherty AM, Hermez KM, Thomason ME
US$ 25.10
US$ 20.87
US$ 24.57
US$ 25.68
US$ 26.43
